Valuation Bio-Rad Laboratories, Inc. NYSE
Stocks
BIO.B
US0905721082
Medical Equipment, Supplies & Distribution
|
Market Closed -
NYSE
00:10:00 21/08/2026 +04
|
5-day change | 1st Jan Change | ||
| 365.08 USD | +8.33% |
|
-.--% | +17.50% |
Company Valuation: Bio-Rad Laboratories, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 22,439 | 12,460 | 9,399 | 9,182 | 8,212 | 9,747 | - | - |
| Change | - | -44.47% | -24.57% | -2.31% | -10.57% | 18.69% | - | - |
| Enterprise Value (EV) 1 | 22,439 | 11,868 | 8,992 | 8,730 | 7,874 | 8,998 | 8,782 | 8,640 |
| Change | - | -47.11% | -24.24% | -2.91% | -9.8% | 14.27% | -2.4% | -1.61% |
| P/E | 5.38x | - | -14.8x | -5.03x | 10.9x | 43.8x | 42.8x | 43.1x |
| PBR | - | 1.27x | 1.05x | 1.41x | 1.11x | - | - | - |
| PEG | - | - | - | -0x | -0x | -0.6x | 18.74x | -61.13x |
| Capitalization / Revenue | 7.68x | 4.45x | 3.52x | 3.58x | 3.18x | 3.79x | 3.71x | 3.67x |
| EV / Revenue | 7.68x | 4.24x | 3.37x | 3.4x | 3.05x | 3.5x | 3.35x | 3.26x |
| EV / EBITDA | 33.1x | 17.8x | 16.8x | 18.2x | 17.4x | 22.7x | 21.5x | 20x |
| EV / EBIT | 39.3x | 22.7x | 23.7x | 26.4x | 25.3x | 30.8x | 27.1x | 25.8x |
| EV / FCF | 41.9x | 127x | 24x | - | - | 28.7x | 29.8x | 26.1x |
| FCF Yield | 2.39% | 0.79% | 4.17% | - | - | 3.49% | 3.36% | 3.83% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 140.6 | - | -21.82 | -65.36 | 27.85 | 8.32 | 8.51 | 8.45 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 2,923 | 2,802 | 2,671 | 2,566 | 2,583 | 2,569 | 2,624 | 2,654 |
| EBITDA 1 | 677.5 | 667.9 | 535.9 | 479.5 | 453.2 | 395.8 | 408.8 | 432.6 |
| EBIT 1 | 571.2 | 524 | 378.9 | 331.3 | 311.6 | 292 | 324 | 334.4 |
| Net income 1 | 4,246 | -3,628 | -637.3 | -1,844 | 759.9 | 224.8 | 229.7 | 228.3 |
| Net Debt 1 | - | -592.5 | -407.6 | -452.1 | -337.7 | -749 | -965.4 | -1,107 |
| Reference price 2 | 755.57 | 420.49 | 322.89 | 328.51 | 302.99 | 364.42 | 364.42 | 364.42 |
| Nbr of stocks (in thousands) | 29,918 | 29,824 | 29,145 | 27,997 | 26,975 | 26,738 | - | - |
| Announcement Date | 10/02/22 | 16/02/23 | 15/02/24 | 13/02/25 | 12/02/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 29.81x | 3.99x | 15.41x | 2.52% | 176B | ||
| 19.66x | 3.56x | 12.74x | 3.06% | 118B | ||
| 22x | 4.32x | 15.07x | 1.27% | 108B | ||
| 25.99x | 2.56x | 10.26x | 2.76% | 75.34B | ||
| 17.8x | 0.21x | 12.98x | 0.73% | 62.03B | ||
| 30.51x | 7.58x | 19.51x | 1.31% | 52.8B | ||
| 36.4x | 3.49x | 11.96x | 2.08% | 51.45B | ||
| 35.48x | 8.82x | 24.71x | -.--% | 41.28B | ||
| 48.26x | 1.32x | 12.25x | 0.2% | 31.37B | ||
| Average | 29.55x | 3.98x | 14.99x | 1.55% | 79.61B | |
| Weighted average by Cap. | 27.18x | 3.88x | 14.62x | 1.92% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- BIO Stock
- BIO.B Stock
- Valuation Bio-Rad Laboratories, Inc.
Select your edition
All financial news and data tailored to specific country editions
















